Logo
Asia Pacific Medical Simulation Market 2020 2026

Asia Pacific Medical Simulation Market 2020 2026

Bonafide Trust 28-11-2020 106 Pages Figures : 45 Tables : 36
Region : Asia-Pacific Category : Lifescience Pharmaceutical

Asia Pacific medical simulation market will grow by 17.19% annually with a total addressable market cap of $4,976.0 million over 2020-2026 owing to growing incidences of chronic disorders and population, rising patient safety concerns, the heightened demand for minimally invasive surgery (MIS), and technological advancement. Highlighted with 36 tables and 45 figures, this 106-page report “Asia Pacific Medical Simulation Market 2020-2026 by Product & Service (Model-based Simulation, Web-based Simulation, Simulation Training Services), Fidelity (High, Medium, Low), End User, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Asia Pacific medical simulation market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific medical simulation market in every aspect of the classification from perspectives of Product & Service, Fidelity, End User, and Country. Based on Product & Service, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. Model-based Simulation • Patient Simulation (further segmented into Manikin-based Simulation, Task Trainer Simulation, Hybrid Manikin-based simulation, Standardized Patient Simulation) • Surgical Simulation (further split into Cardiovascular Simulators, Laparoscopic Surgical Simulators, Gynecology Simulators, Arthroscopic Surgical Simulators, Orthopedic Simulators, Endovascular Simulators, Spine Simulators, Other Surgical Simulations) • Ultrasound Simulation (further segmented into Cardiology, Anesthesia, Intensive Care Unit, Emergency Medicine, OB/GYN, Radiology, Other Ultrasound Simulations) Web-based Simulation • Virtual Tutors • Performance Recording Software • Simulation Software • Learning Management Software Simulation Training Services • Vendor-based Training • Custom Consulting Services • Educational Societies Based on Fidelity, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. • Low-fidelity • Medium-fidelity • High-fidelity Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section. • Academic Institutions & Research Centers • Hospitals & Clinics • Military Organizations • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Product & Service, Fidelity, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific medical simulation market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): 3D Systems Corporation Canadian Aviation Electronics, Ltd. (CAE) Gaumard Scientific Company Intelligent Ultrasound Group Plc (Formerly Medaphor Group Plc) Kyoto Kagaku Co., Ltd. Laerdal Medical AS Limbs & Things Ltd. Mentice AB Simulab Corporation Simulaids, Inc. Surgical Science Sweden AB Virtamed AG (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services